Astrana Health Inc. Common Stock

ASTH · Management Consulting Services · $1.9B
Cooling off
Not on a screen at the moment — no base, so no pivot to draw. The price and volume are below.
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year
The read

Astrana Health Inc. Common Stock is not on any of the screens right now. Its relative strength rating is 59, and it sits in Management Consulting Services.

Peers
Same theme
No themes — common and fine.
Catalyst roadmap

Nothing dated in the next three months that we can ingest automatically.

Flagged by the market sweep
GappedTape · 2026-09-18
-9.0%
Unusual volumeTape · 2026-09-18
4.0 sigma
Red flag in a filingFiling · 2026-09-16
material weakness

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means.

In the news

No headlines for this company in the last couple of weeks.

Insiders

No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.

X-ray

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. Historical figures are backtests and are hypothetical.

What that means, in full
Astrana Health Inc. Common Stock (ASTH) — The Tape